These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 18448286)

  • 21. Thermosensitive β-cyclodextrin modified poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles prolong the anti-inflammatory effect of indomethacin following local injection.
    Wei X; Lv X; Zhao Q; Qiu L
    Acta Biomater; 2013 Jun; 9(6):6953-63. PubMed ID: 23416577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles.
    Qiu N; Cai LL; Xie D; Wang G; Wu W; Zhang Y; Song H; Yin H; Chen L
    Biomed Mater; 2010 Dec; 5(6):065006. PubMed ID: 20966535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.
    Gong CY; Shi S; Dong PW; Zheng XL; Fu SZ; Guo G; Yang JL; Wei YQ; Qian ZY
    BMC Biotechnol; 2009 Feb; 9():8. PubMed ID: 19210779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery.
    Li J; Li X; Ni X; Wang X; Li H; Leong KW
    Biomaterials; 2006 Aug; 27(22):4132-40. PubMed ID: 16584769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composite microparticles with in vivo reduction of the burst release effect.
    Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
    Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity.
    Gou M; Dai M; Li X; Yang L; Huang M; Wang Y; Kan B; Lu Y; Wei Y; Qian Z
    Colloids Surf B Biointerfaces; 2008 Jun; 64(1):135-9. PubMed ID: 18249528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan.
    Li X; Zheng X; Wei X; Guo G; Gou M; Gong C; Wang X; Dai M; Chen L; Wei Y; Qian Z
    J Nanosci Nanotechnol; 2009 Aug; 9(8):4586-92. PubMed ID: 19928122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery.
    Wang N; Wu XS
    Pharm Dev Technol; 1997 May; 2(2):135-42. PubMed ID: 9552439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermoresponsive biodegradable PEG-PCL-PEG based injectable hydrogel for pulsatile insulin delivery.
    Payyappilly S; Dhara S; Chattopadhyay S
    J Biomed Mater Res A; 2014 May; 102(5):1500-9. PubMed ID: 23681592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalized injectable hydrogels for controlled insulin delivery.
    Huynh DP; Nguyen MK; Pi BS; Kim MS; Chae SY; Lee KC; Kim BS; Kim SW; Lee DS
    Biomaterials; 2008 Jun; 29(16):2527-34. PubMed ID: 18329707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel drug and gene co-delivery system based on Poly(epsilon-caprolactone)-Poly(ethylene glycol)-Poly(epsilon-caprolactone) grafted polyethyleneimine micelle.
    Men K; Gou ML; Guo QF; Wang XH; Shi S; Kan B; Huang MJ; Luo F; Chen LJ; Zhao X; Qian ZY; Liang SF; Wei YQ
    J Nanosci Nanotechnol; 2010 Dec; 10(12):7958-64. PubMed ID: 21121283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers.
    Chen C; Yu CH; Cheng YC; Yu PH; Cheung MK
    Biomaterials; 2006 Sep; 27(27):4804-14. PubMed ID: 16740306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism.
    Babasola IO; Zhang W; Amsden BG
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):765-72. PubMed ID: 23665446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
    Yu L; Chang GT; Zhang H; Ding JD
    Int J Pharm; 2008 Feb; 348(1-2):95-106. PubMed ID: 17825508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery.
    Li R; Li X; Xie L; Ding D; Hu Y; Qian X; Yu L; Ding Y; Jiang X; Liu B
    Int J Pharm; 2009 Sep; 379(1):158-66. PubMed ID: 19524653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone) as parenteral drug-delivery systems.
    Cho H; Chung D; Jeongho A
    Biomaterials; 2004 Aug; 25(17):3733-42. PubMed ID: 15020149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.